The Hindu·3 min read·medium
India approves first dengue vaccine for individuals aged 4 to 60 years
T
The Hindu Bureau
✦AI Summary
India has approved Takeda’s QDENGA, the country's first dengue vaccine, for individuals aged 4 to 60. The vaccine, which protects against all four dengue serotypes, has shown high efficacy in preventing hospitalizations in long-term clinical trials.
The Drug Controller General of India (DCGI) has granted market authorisation to Takeda Biopharmaceuticals India’s QDENGA (TAK-003), making it the first dengue vaccine to be approved in the country, according to a press release issued by the company.
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in